Michael Higgins, Chief Executive Officer
Michael Higgins has served as a member of the Kindex Board of Directors since February, 2015. Michael brings more than 25 years of experience in the Biopharmaceutical industry working with large multi-national organizations and small entrepreneurial firms. He has held leadership roles in Finance, Operations and Business Development. Mr. Higgins is currently an Entrepreneur-in-residence at Polaris Venture Partners. Prior to joining Kindex, Michael served as Chief Operating Officer and Chief Financial Officer at Ironwood Pharmaceuticals from 2003 through 2014. Prior to his work at Ironwood, Mr. Higgins spent seven years at Genzyme Corporation in a variety of leadership roles including Vice President, Corporate Finance and Vice President, Business Development. Michael aslos served as Chief Financial Officer of Procept, Inc. Michael earned his Bachelor of Science degree from Cornell University and holds a Masters in Business Administration from the Amos Tuck School of Business at Dartmouth College.
Paul Rogers, Chief Business Officer
Paul brings more than 30 years of experience in the Biopharmaceutical industry working with large multi-national organizations and small entrepreneurial firms. Paul has held Senior Leadership roles in Commercial and R&D. Prior to joining Kindex, Paul served as Vice president Product Development and Commercial Operations at Medgnics, Inc. Prior to his work at Medgenics, Paul spent four years at Ironwood Pharmaceuticals as the Vice President of Global Marketing and the Head of Emerging Products. Paul also served as Vice President/General Manager Shire Pharmaceuticals and Vice President of Marketing at Astra Zeneca. Paul earned his MBA at Saint Joseph’s University and his Master’s Degree in Clinical Immunology at Hahnemann University.
Robert Busby, Head Preclinical Development and Clinical Pharmacology
Rob Busby joined Kindex in February, 2019. Rob brings more than 20 years of experience in the Biopharmaceutical industry. Rob has held senior level R&D roles in Large and small pharmaceutical companies. Prior to joining Kindex, Rob served as Vice President, Analytical Pharmacology, Drug Metabolism and Clinical Pharmacology at Ironwood Pharmaceuticals. Rob also served as the Director, Bioanalytical Sciences and Director, Lead Development at Microbia, Inc. Rob earned his Ph.D. from John’s Hopkin’s University.
Eduardo Martinez, Head of Chemistry
Eduardo brings more than 20 years of experience in the Biopharmaceutical industry. Eduardo has held senior level R&D roles in Large and small pharmaceutical companies. Prior to joining Kindex, Eduardo served as Vice President, Chemistry at Rgenix Inc. Eduardo also co-founded Euclises Pharma. Eduardo earned his Ph.D. from Harvard University.